Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday
Gainers
Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued above the mid-six-figures.
Coinbase Global And 3 Other Stocks Insiders Are Buying
Although US stocks closed lower on Thursday, there were a few notable insider trades.
Why WISeKey International Is Trading Higher By Over 20%; Here Are 29 Stocks Moving Premarket
Gainers
Statera Biopharma, Inc. (NASDAQ: STAB) rose 89.4% to $0.2655 in pre-market trading. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of Radiation-Related Disorders."
Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday
Gainers
Chardan NexTech Acquisition 2 Corp. (NASDAQ: CNTQ) shares surged 102.6% to close at $21.54 on Wednesday.
Biohaven’s ALS Drug Fails To Meet Study Endpoint, Second Therapy To Fail Trials In Recent Months
Biohaven Pharmaceutical Holding Company Ltd (NASDAQ: BHVN) announced results from a focused analysis of verdiperstat in the HEALEY ALS Platform Trial in amyotrophic lateral sclerosis (ALS).
Biohaven Provides Update From Pivotal Phase 2/3 Trial With Verdiperstat In Amyotrophic Lateral Sclerosis
Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) today announced results from a focused analysis of treatment with verdiperstat in the HEALEY ALS Platform Trial in amyotrophic lateral sclerosis (ALS). The HEALEY
Biohaven Pharmaceutical Announced Record Date of September 26, 2022 for the Previously Announced Spin-off of Its Biohaven Ltd. Subsidiary
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven") today announced that it has set a record date of September 26, 2022 (the "Record Date") for the previously announced spin-off by Biohaven of its Biohaven Ltd.